<DOC>
	<DOCNO>NCT02122718</DOCNO>
	<brief_summary>Recurrent stroke cognitive decline common ischaemic stroke . Allopurinol , drug usually use treat gout , show reduce heart ischaemia , heart size , arterial stiffness relax brain blood vessel may reduce blood pressure . All property may associate low risk second stroke cognitive decline . We aim explore whether allopurinol reduce damage brain ( call white matter hyper-intensities ) stroke also whether reduces heart size blood pressure stroke . We conduct multi-centre randomise , double-blind placebo control study investigate whether two year allopurinol 300 mg twice per day ( BD ) improve 3 outcome , inextricably link risk recurrence cognitive decline ischaemic stroke .</brief_summary>
	<brief_title>Xanthine Oxidase Inhibition Improvement Long-term Outcomes Following Ischaemic Stroke Transient Ischaemic Attack</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>Ischaemic Stroke/ Ischaemic lesion brain imaging relevant anatomical territory patient transient ischaemic attack . Age great 50 year . Consent within one month stroke . Modified Rankin scale score 5 ( end possible enrolment window one month stroke ) . Diagnosis dementia ( define document diagnosis screen Informant Questionnaire Cognitive Decline Elderly ( IQCODE ) score 3.6 ) . Cognitive impairment deem sufficient compromise capacity consent comply protocol ( opinion local investigator ) . Dependent daily help others basic instrumental activity daily live prior stroke ( define assistance need toileting , walk dress ) . Significant comorbidity frailty likely cause death within 24 month likely make adherence study protocol difficult participant ( opinion local investigator ) . Contraindication indication administration allopurinol ( detailed Summary Product Characteristics XILOFIST web portal trial master file ) . Concurrent azathioprine , 6mercaptopurine therapy , cytotoxic therapy , cyclosporin , theophylline didanosine . Significant hepatic impairment ( define serum bilirubin , Aspartate Aminotransferase ( AST ) Alanine transaminase ( ALT ) great three time upper limit normal ( ULN ) ) . Estimated Glomerular Filtration Rate &lt; 30 mls/min Contraindication MRI scan . Women pregnant breastfeeding . Women childbearing potential unable unwilling use contraception . Prisoners . Active participation another Clinical Trial Investigational Medicinal Product ( CTIMP ) device trial participation within past month .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>